Skip to main content
. 2017 Jun 29;2017(6):CD011412. doi: 10.1002/14651858.CD011412.pub2
Methods Randomised trial conducted in China
2 treatment arms: CBZ and OXC
Participants Children aged 2‐14 years, who were newly diagnosed with focal epilepsy between October 2009 and December 2011
Number randomised: CBZ = 60, OXC = 58
Interventions Monotherapy with CBZ or OXC
Doses started and achieved not stated
Outcomes Response rates
Seizure‐free rates
Adverse event rates
Notes 2 publications of the trial available only in Chinese (English abstract). Awaiting translation of the full text